The number of both Aldh1+ve and CD133+ve cells were substantially increased to 55-65% in enriched 3D-tumor spheres prior to drug treatment when compared to parental cells for H1048 and H1882 cell lines (Fig. 1c–f). Here, ALDH1A1 is linked to neoplasm.